AbbVie
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $15,102,000 | $14,460,000 | $14,462,000 | $12,310,000 |
Gross Profit | 10,706,000 | 10,248,000 | 12,286,000 | 8,228,000 |
EBITDA | 535,000 | 4,933,000 | 7,129,000 | 5,557,000 |
EBIT | -1,567,000 | 2,854,000 | 4,998,000 | 3,483,000 |
Net Income | -22,000 | 1,561,000 | 1,370,000 | 1,369,000 |
Net Change In Cash | 15,102,000 | 14,460,000 | 14,462,000 | 12,310,000 |
Free Cash Flow | 6,757,000 | 5,198,000 | 2,030,000 | 3,847,000 |
Cash | 5,524,000 | 7,257,000 | 13,130,000 | 18,067,000 |
Basic Shares | 1,769,000 | 1,772,000 | 1,771,000 | 1,773,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $56,334,000 | $54,318,000 | $58,054,000 | $56,197,000 |
Gross Profit | 39,430,000 | 33,903,000 | 40,640,000 | 38,751,000 |
EBITDA | 14,910,000 | 17,308,000 | 31,424,000 | 28,280,000 |
EBIT | 6,524,000 | 8,610,000 | 22,957,000 | 19,759,000 |
Net Income | 4,278,000 | 4,863,000 | 11,836,000 | 11,542,000 |
Net Change In Cash | 56,334,000 | 54,318,000 | 58,054,000 | 56,197,000 |
Cost of Revenue | -483,000 | 1,297,000 | ||
Free Cash Flow | 18,806,000 | 22,062,000 | 24,248,000 | 21,990,000 |
Cash | 5,524,000 | 12,814,000 | 9,201,000 | 9,746,000 |
Basic Shares | 1,773,000 | 1,773,000 | 1,778,000 | 1,777,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $2.16 |
2024-09-30 | $3 |
2024-06-30 | $2.65 |
2024-03-31 | $2.31 |
